However, this correlates with the previously reported high Gpr84 expression in microglia in different disease models such as endotoxemia, experimental autoimmune encephalomyelitis, Alzheimer, and neuronal injury (34–36). This evidence concerns the gene GPR84 and serum lipopolysaccharide activity.